153 related articles for article (PubMed ID: 23377669)
1. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway.
Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y
J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669
[TBL] [Abstract][Full Text] [Related]
2. Potent antirheumatic activity of a new DNA vaccine targeted to B7-2/CD28 costimulatory signaling pathway in autoimmune arthritis.
Xue H; Liang F; Liu N; Song X; Yuan F; Luo Y; Zhao X; Long J; Sun Y; Xi Y
Hum Gene Ther; 2011 Jan; 22(1):65-76. PubMed ID: 20695769
[TBL] [Abstract][Full Text] [Related]
3. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C
J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121
[TBL] [Abstract][Full Text] [Related]
4. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW; Smith EC
Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
6. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
[TBL] [Abstract][Full Text] [Related]
7. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
[TBL] [Abstract][Full Text] [Related]
8. During acute graft versus host disease CD28 deletion in donor CD8
Uri A; Lühder F; Kerkau T; Beyersdorf N
Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
[TBL] [Abstract][Full Text] [Related]
9. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
10. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR
Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238
[TBL] [Abstract][Full Text] [Related]
11. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines.
Popugailo A; Rotfogel Z; Supper E; Hillman D; Kaempfer R
Front Immunol; 2019; 10():942. PubMed ID: 31114583
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway.
Agranovich I; Scott DE; Terle D; Lee K; Golding B
Infect Immun; 1999 Sep; 67(9):4418-26. PubMed ID: 10456882
[TBL] [Abstract][Full Text] [Related]
14. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
15. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
[TBL] [Abstract][Full Text] [Related]
16. Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody.
Beyersdorf N; Ding X; Blank G; Dennehy KM; Kerkau T; Hünig T
Blood; 2008 Nov; 112(10):4328-36. PubMed ID: 18780833
[TBL] [Abstract][Full Text] [Related]
17. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.
Erdmann AA; Gao ZG; Jung U; Foley J; Borenstein T; Jacobson KA; Fowler DH
Blood; 2005 Jun; 105(12):4707-14. PubMed ID: 15746085
[TBL] [Abstract][Full Text] [Related]
18. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
19. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.
Montagnoli C; Bacci A; Bozza S; Gaziano R; Mosci P; Sharpe AH; Romani L
J Immunol; 2002 Dec; 169(11):6298-308. PubMed ID: 12444136
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
